Growth Metrics

MDxHealth (MDXH) Cash & Equivalents (2020 - 2025)

Historic Cash & Equivalents for MDxHealth (MDXH) over the last 6 years, with Q3 2025 value amounting to $46.8 million.

  • MDxHealth's Cash & Equivalents fell 502.11% to $46.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.8 million, marking a year-over-year decrease of 502.11%. This contributed to the annual value of $22.4 million for FY2024, which is 0.0% changed from last year.
  • According to the latest figures from Q3 2025, MDxHealth's Cash & Equivalents is $46.8 million, which was down 502.11% from $46.8 million recorded in Q2 2025.
  • MDxHealth's Cash & Equivalents' 5-year high stood at $65.7 million during Q1 2025, with a 5-year trough of $14.5 million in Q1 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $43.4 million (2022), whereas its average is $39.1 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first crashed by 7349.82% in 2022, then skyrocketed by 35309.78% in 2025.
  • Quarter analysis of 5 years shows MDxHealth's Cash & Equivalents stood at $58.5 million in 2021, then tumbled by 73.5% to $15.5 million in 2022, then soared by 44.36% to $22.4 million in 2023, then skyrocketed by 109.11% to $46.8 million in 2024, then changed by 0.0% to $46.8 million in 2025.
  • Its Cash & Equivalents was $46.8 million in Q3 2025, compared to $46.8 million in Q2 2025 and $65.7 million in Q1 2025.